A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes

Bristol-Myers Squibb (BMS)

Status and phase: Completed; Phase 4

Conditions: Diabetes Mellitus, Non-Insulin-Dependent

Treatments: Drug: or Metformin HCl alone; Drug: Glucovance (metformin HCl/glyburide); Drug: or Glyburide alone.

Study type: Interventional

Funder types: Industry

Identifiers

NCT00035568

CV138-062

Details and patient eligibility

About

The purpose of this clinical research study is to support earlier observations that Glucovance controls glucose levels after a mean, and improves overall glucose control better than metformin or glyburide therapy alone in adults with type 2 diabetes.

Sex: All

Ages: 20 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Adults 20-75 with a diagnosis of type 2 diabetes mellitus who are not adequately controlled with diet and exercise, and have an HbA1c greater than 6.7%